[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Passive Transdermal Drug Delivery Sales Market Report 2018

March 2018 | 117 pages | ID: G5DEC5C2179QEN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the global Passive Transdermal Drug Delivery market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Passive Transdermal Drug Delivery for these regions, from 2013 to 2025 (forecast), covering
  • United States
  • China
  • Europe
  • Japan
  • Southeast Asia
  • India
Global Passive Transdermal Drug Delivery market competition by top manufacturers/players, with Passive Transdermal Drug Delivery sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
  • 3M
  • Actavis, Inc.
  • Bayer AG
  • Boehringer Ingelheim GmbH
  • Corium International, Inc.
  • Echo Therapeutics, Inc.
  • GlaxoSmithKline plc
  • Johnson & Johnson (Janssen Pharmaceuticals Inc.)
  • Mylan N.V.
  • Novartis AG
  • Noven Pharmaceuticals, Inc.
  • Transdermal Corp.
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • Microfluidics
  • Smart Pill Technology (SPT)
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Clinic
  • Hospital
  • Others
If you have any special requirements, please let us know and we will offer you the report as you want.
Global Passive Transdermal Drug Delivery Sales Market Report 2018

1 PASSIVE TRANSDERMAL DRUG DELIVERY MARKET OVERVIEW

1.1 Product Overview and Scope of Passive Transdermal Drug Delivery
1.2 Classification of Passive Transdermal Drug Delivery by Product Category
  1.2.1 Global Passive Transdermal Drug Delivery Market Size (Sales) Comparison by Type (2013-2025)
  1.2.2 Global Passive Transdermal Drug Delivery Market Size (Sales) Market Share by Type (Product Category) in 2017
  1.2.3 Microfluidics
  1.2.4 Smart Pill Technology (SPT)
1.3 Global Passive Transdermal Drug Delivery Market by Application/End Users
  1.3.1 Global Passive Transdermal Drug Delivery Sales (Volume) and Market Share Comparison by Application (2013-2025)
  1.3.2 Clinic
  1.3.3 Hospital
  1.3.4 Others
1.4 Global Passive Transdermal Drug Delivery Market by Region
  1.4.1 Global Passive Transdermal Drug Delivery Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 United States Passive Transdermal Drug Delivery Status and Prospect (2013-2025)
  1.4.3 China Passive Transdermal Drug Delivery Status and Prospect (2013-2025)
  1.4.4 Europe Passive Transdermal Drug Delivery Status and Prospect (2013-2025)
  1.4.5 Japan Passive Transdermal Drug Delivery Status and Prospect (2013-2025)
  1.4.6 Southeast Asia Passive Transdermal Drug Delivery Status and Prospect (2013-2025)
  1.4.7 India Passive Transdermal Drug Delivery Status and Prospect (2013-2025)
1.5 Global Market Size (Value and Volume) of Passive Transdermal Drug Delivery (2013-2025)
  1.5.1 Global Passive Transdermal Drug Delivery Sales and Growth Rate (2013-2025)
  1.5.2 Global Passive Transdermal Drug Delivery Revenue and Growth Rate (2013-2025)

2 GLOBAL PASSIVE TRANSDERMAL DRUG DELIVERY COMPETITION BY PLAYERS/SUPPLIERS, TYPE AND APPLICATION

2.1 Global Passive Transdermal Drug Delivery Market Competition by Players/Suppliers
  2.1.1 Global Passive Transdermal Drug Delivery Sales and Market Share of Key Players/Suppliers (2013-2018)
  2.1.2 Global Passive Transdermal Drug Delivery Revenue and Share by Players/Suppliers (2013-2018)
2.2 Global Passive Transdermal Drug Delivery (Volume and Value) by Type
  2.2.1 Global Passive Transdermal Drug Delivery Sales and Market Share by Type (2013-2018)
  2.2.2 Global Passive Transdermal Drug Delivery Revenue and Market Share by Type (2013-2018)
2.3 Global Passive Transdermal Drug Delivery (Volume and Value) by Region
  2.3.1 Global Passive Transdermal Drug Delivery Sales and Market Share by Region (2013-2018)
  2.3.2 Global Passive Transdermal Drug Delivery Revenue and Market Share by Region (2013-2018)
2.4 Global Passive Transdermal Drug Delivery (Volume) by Application

3 UNITED STATES PASSIVE TRANSDERMAL DRUG DELIVERY (VOLUME, VALUE AND SALES PRICE)

3.1 United States Passive Transdermal Drug Delivery Sales and Value (2013-2018)
  3.1.1 United States Passive Transdermal Drug Delivery Sales and Growth Rate (2013-2018)
  3.1.2 United States Passive Transdermal Drug Delivery Revenue and Growth Rate (2013-2018)
  3.1.3 United States Passive Transdermal Drug Delivery Sales Price Trend (2013-2018)
3.2 United States Passive Transdermal Drug Delivery Sales Volume and Market Share by Players (2013-2018)
3.3 United States Passive Transdermal Drug Delivery Sales Volume and Market Share by Type (2013-2018)
3.4 United States Passive Transdermal Drug Delivery Sales Volume and Market Share by Application (2013-2018)

4 CHINA PASSIVE TRANSDERMAL DRUG DELIVERY (VOLUME, VALUE AND SALES PRICE)

4.1 China Passive Transdermal Drug Delivery Sales and Value (2013-2018)
  4.1.1 China Passive Transdermal Drug Delivery Sales and Growth Rate (2013-2018)
  4.1.2 China Passive Transdermal Drug Delivery Revenue and Growth Rate (2013-2018)
  4.1.3 China Passive Transdermal Drug Delivery Sales Price Trend (2013-2018)
4.2 China Passive Transdermal Drug Delivery Sales Volume and Market Share by Players (2013-2018)
4.3 China Passive Transdermal Drug Delivery Sales Volume and Market Share by Type (2013-2018)
4.4 China Passive Transdermal Drug Delivery Sales Volume and Market Share by Application (2013-2018)

5 EUROPE PASSIVE TRANSDERMAL DRUG DELIVERY (VOLUME, VALUE AND SALES PRICE)

5.1 Europe Passive Transdermal Drug Delivery Sales and Value (2013-2018)
  5.1.1 Europe Passive Transdermal Drug Delivery Sales and Growth Rate (2013-2018)
  5.1.2 Europe Passive Transdermal Drug Delivery Revenue and Growth Rate (2013-2018)
  5.1.3 Europe Passive Transdermal Drug Delivery Sales Price Trend (2013-2018)
5.2 Europe Passive Transdermal Drug Delivery Sales Volume and Market Share by Players (2013-2018)
5.3 Europe Passive Transdermal Drug Delivery Sales Volume and Market Share by Type (2013-2018)
5.4 Europe Passive Transdermal Drug Delivery Sales Volume and Market Share by Application (2013-2018)

6 JAPAN PASSIVE TRANSDERMAL DRUG DELIVERY (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Passive Transdermal Drug Delivery Sales and Value (2013-2018)
  6.1.1 Japan Passive Transdermal Drug Delivery Sales and Growth Rate (2013-2018)
  6.1.2 Japan Passive Transdermal Drug Delivery Revenue and Growth Rate (2013-2018)
  6.1.3 Japan Passive Transdermal Drug Delivery Sales Price Trend (2013-2018)
6.2 Japan Passive Transdermal Drug Delivery Sales Volume and Market Share by Players (2013-2018)
6.3 Japan Passive Transdermal Drug Delivery Sales Volume and Market Share by Type (2013-2018)
6.4 Japan Passive Transdermal Drug Delivery Sales Volume and Market Share by Application (2013-2018)

7 SOUTHEAST ASIA PASSIVE TRANSDERMAL DRUG DELIVERY (VOLUME, VALUE AND SALES PRICE)

7.1 Southeast Asia Passive Transdermal Drug Delivery Sales and Value (2013-2018)
  7.1.1 Southeast Asia Passive Transdermal Drug Delivery Sales and Growth Rate (2013-2018)
  7.1.2 Southeast Asia Passive Transdermal Drug Delivery Revenue and Growth Rate (2013-2018)
  7.1.3 Southeast Asia Passive Transdermal Drug Delivery Sales Price Trend (2013-2018)
7.2 Southeast Asia Passive Transdermal Drug Delivery Sales Volume and Market Share by Players (2013-2018)
7.3 Southeast Asia Passive Transdermal Drug Delivery Sales Volume and Market Share by Type (2013-2018)
7.4 Southeast Asia Passive Transdermal Drug Delivery Sales Volume and Market Share by Application (2013-2018)

8 INDIA PASSIVE TRANSDERMAL DRUG DELIVERY (VOLUME, VALUE AND SALES PRICE)

8.1 India Passive Transdermal Drug Delivery Sales and Value (2013-2018)
  8.1.1 India Passive Transdermal Drug Delivery Sales and Growth Rate (2013-2018)
  8.1.2 India Passive Transdermal Drug Delivery Revenue and Growth Rate (2013-2018)
  8.1.3 India Passive Transdermal Drug Delivery Sales Price Trend (2013-2018)
8.2 India Passive Transdermal Drug Delivery Sales Volume and Market Share by Players (2013-2018)
8.3 India Passive Transdermal Drug Delivery Sales Volume and Market Share by Type (2013-2018)
8.4 India Passive Transdermal Drug Delivery Sales Volume and Market Share by Application (2013-2018)

9 GLOBAL PASSIVE TRANSDERMAL DRUG DELIVERY PLAYERS/SUPPLIERS PROFILES AND SALES DATA

9.1 3M
  9.1.1 Company Basic Information, Manufacturing Base and Competitors
  9.1.2 Passive Transdermal Drug Delivery Product Category, Application and Specification
    9.1.2.1 Product A
    9.1.2.2 Product B
  9.1.3 3M Passive Transdermal Drug Delivery Sales, Revenue, Price and Gross Margin (2013-2018)
  9.1.4 Main Business/Business Overview
9.2 Actavis, Inc.
  9.2.1 Company Basic Information, Manufacturing Base and Competitors
  9.2.2 Passive Transdermal Drug Delivery Product Category, Application and Specification
    9.2.2.1 Product A
    9.2.2.2 Product B
  9.2.3 Actavis, Inc. Passive Transdermal Drug Delivery Sales, Revenue, Price and Gross Margin (2013-2018)
  9.2.4 Main Business/Business Overview
9.3 Bayer AG
  9.3.1 Company Basic Information, Manufacturing Base and Competitors
  9.3.2 Passive Transdermal Drug Delivery Product Category, Application and Specification
    9.3.2.1 Product A
    9.3.2.2 Product B
  9.3.3 Bayer AG Passive Transdermal Drug Delivery Sales, Revenue, Price and Gross Margin (2013-2018)
  9.3.4 Main Business/Business Overview
9.4 Boehringer Ingelheim GmbH
  9.4.1 Company Basic Information, Manufacturing Base and Competitors
  9.4.2 Passive Transdermal Drug Delivery Product Category, Application and Specification
    9.4.2.1 Product A
    9.4.2.2 Product B
  9.4.3 Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Sales, Revenue, Price and Gross Margin (2013-2018)
  9.4.4 Main Business/Business Overview
9.5 Corium International, Inc.
  9.5.1 Company Basic Information, Manufacturing Base and Competitors
  9.5.2 Passive Transdermal Drug Delivery Product Category, Application and Specification
    9.5.2.1 Product A
    9.5.2.2 Product B
  9.5.3 Corium International, Inc. Passive Transdermal Drug Delivery Sales, Revenue, Price and Gross Margin (2013-2018)
  9.5.4 Main Business/Business Overview
9.6 Echo Therapeutics, Inc.
  9.6.1 Company Basic Information, Manufacturing Base and Competitors
  9.6.2 Passive Transdermal Drug Delivery Product Category, Application and Specification
    9.6.2.1 Product A
    9.6.2.2 Product B
  9.6.3 Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Sales, Revenue, Price and Gross Margin (2013-2018)
  9.6.4 Main Business/Business Overview
9.7 GlaxoSmithKline plc
  9.7.1 Company Basic Information, Manufacturing Base and Competitors
  9.7.2 Passive Transdermal Drug Delivery Product Category, Application and Specification
    9.7.2.1 Product A
    9.7.2.2 Product B
  9.7.3 GlaxoSmithKline plc Passive Transdermal Drug Delivery Sales, Revenue, Price and Gross Margin (2013-2018)
  9.7.4 Main Business/Business Overview
9.8 Johnson & Johnson (Janssen Pharmaceuticals Inc.)
  9.8.1 Company Basic Information, Manufacturing Base and Competitors
  9.8.2 Passive Transdermal Drug Delivery Product Category, Application and Specification
    9.8.2.1 Product A
    9.8.2.2 Product B
  9.8.3 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Sales, Revenue, Price and Gross Margin (2013-2018)
  9.8.4 Main Business/Business Overview
9.9 Mylan N.V.
  9.9.1 Company Basic Information, Manufacturing Base and Competitors
  9.9.2 Passive Transdermal Drug Delivery Product Category, Application and Specification
    9.9.2.1 Product A
    9.9.2.2 Product B
  9.9.3 Mylan N.V. Passive Transdermal Drug Delivery Sales, Revenue, Price and Gross Margin (2013-2018)
  9.9.4 Main Business/Business Overview
9.10 Novartis AG
  9.10.1 Company Basic Information, Manufacturing Base and Competitors
  9.10.2 Passive Transdermal Drug Delivery Product Category, Application and Specification
    9.10.2.1 Product A
    9.10.2.2 Product B
  9.10.3 Novartis AG Passive Transdermal Drug Delivery Sales, Revenue, Price and Gross Margin (2013-2018)
  9.10.4 Main Business/Business Overview
9.11 Noven Pharmaceuticals, Inc.
9.12 Transdermal Corp.

10 PASSIVE TRANSDERMAL DRUG DELIVERY MAUFACTURING COST ANALYSIS

10.1 Passive Transdermal Drug Delivery Key Raw Materials Analysis
  10.1.1 Key Raw Materials
  10.1.2 Price Trend of Key Raw Materials
  10.1.3 Key Suppliers of Raw Materials
  10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
  10.2.1 Raw Materials
  10.2.2 Labor Cost
  10.2.3 Manufacturing Process Analysis of Passive Transdermal Drug Delivery
10.3 Manufacturing Process Analysis of Passive Transdermal Drug Delivery

11 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

11.1 Passive Transdermal Drug Delivery Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Passive Transdermal Drug Delivery Major Manufacturers in 2017
11.4 Downstream Buyers

12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

12.1 Marketing Channel
  12.1.1 Direct Marketing
  12.1.2 Indirect Marketing
  12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
  12.2.1 Pricing Strategy
  12.2.2 Brand Strategy
  12.2.3 Target Client
12.3 Distributors/Traders List

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes Threat
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 GLOBAL PASSIVE TRANSDERMAL DRUG DELIVERY MARKET FORECAST (2018-2025)

14.1 Global Passive Transdermal Drug Delivery Sales Volume, Revenue and Price Forecast (2018-2025)
  14.1.1 Global Passive Transdermal Drug Delivery Sales Volume and Growth Rate Forecast (2018-2025)
  14.1.2 Global Passive Transdermal Drug Delivery Revenue and Growth Rate Forecast (2018-2025)
  14.1.3 Global Passive Transdermal Drug Delivery Price and Trend Forecast (2018-2025)
14.2 Global Passive Transdermal Drug Delivery Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
  14.2.1 Global Passive Transdermal Drug Delivery Sales Volume and Growth Rate Forecast by Regions (2018-2025)
  14.2.2 Global Passive Transdermal Drug Delivery Revenue and Growth Rate Forecast by Regions (2018-2025)
  14.2.3 United States Passive Transdermal Drug Delivery Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
  14.2.4 China Passive Transdermal Drug Delivery Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
  14.2.5 Europe Passive Transdermal Drug Delivery Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
  14.2.6 Japan Passive Transdermal Drug Delivery Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
  14.2.7 Southeast Asia Passive Transdermal Drug Delivery Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
  14.2.8 India Passive Transdermal Drug Delivery Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.3 Global Passive Transdermal Drug Delivery Sales Volume, Revenue and Price Forecast by Type (2018-2025)
  14.3.1 Global Passive Transdermal Drug Delivery Sales Forecast by Type (2018-2025)
  14.3.2 Global Passive Transdermal Drug Delivery Revenue Forecast by Type (2018-2025)
  14.3.3 Global Passive Transdermal Drug Delivery Price Forecast by Type (2018-2025)
14.4 Global Passive Transdermal Drug Delivery Sales Volume Forecast by Application (2018-2025)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

16.1 Methodology/Research Approach
  16.1.1 Research Programs/Design
  16.1.2 Market Size Estimation
  16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
  16.2.1 Secondary Sources
  16.2.2 Primary Sources
16.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.


LIST OF TABLES AND FIGURES

Figure Product Picture of Passive Transdermal Drug Delivery
Figure Global Passive Transdermal Drug Delivery Sales Volume Comparison (K Units) by Type (2013-2025)
Figure Global Passive Transdermal Drug Delivery Sales Volume Market Share by Type (Product Category) in 2017
Figure Microfluidics Product Picture
Figure Smart Pill Technology (SPT) Product Picture
Figure Global Passive Transdermal Drug Delivery Sales Comparison (K Units) by Application (2013-2025)
Figure Global Sales Market Share of Passive Transdermal Drug Delivery by Application in 2017
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Others Examples
Table Key Downstream Customer in Others
Figure Global Passive Transdermal Drug Delivery Market Size (Million USD) by Regions (2013-2025)
Figure United States Passive Transdermal Drug Delivery Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Passive Transdermal Drug Delivery Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Passive Transdermal Drug Delivery Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Passive Transdermal Drug Delivery Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Passive Transdermal Drug Delivery Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Passive Transdermal Drug Delivery Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Passive Transdermal Drug Delivery Sales Volume (K Units) and Growth Rate (2013-2025)
Figure Global Passive Transdermal Drug Delivery Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Market Major Players Passive Transdermal Drug Delivery Sales Volume (K Units) (2013-2018)
Table Global Passive Transdermal Drug Delivery Sales (K Units) of Key Players/Suppliers (2013-2018)
Table Global Passive Transdermal Drug Delivery Sales Share by Players/Suppliers (2013-2018)
Figure 2017 Passive Transdermal Drug Delivery Sales Share by Players/Suppliers
Figure 2017 Passive Transdermal Drug Delivery Sales Share by Players/Suppliers
Figure Global Passive Transdermal Drug Delivery Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Passive Transdermal Drug Delivery Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Passive Transdermal Drug Delivery Revenue Share by Players/Suppliers (2013-2018)
Table 2017 Global Passive Transdermal Drug Delivery Revenue Share by Players
Table 2017 Global Passive Transdermal Drug Delivery Revenue Share by Players
Table Global Passive Transdermal Drug Delivery Sales (K Units) and Market Share by Type (2013-2018)
Table Global Passive Transdermal Drug Delivery Sales Share (K Units) by Type (2013-2018)
Figure Sales Market Share of Passive Transdermal Drug Delivery by Type (2013-2018)
Figure Global Passive Transdermal Drug Delivery Sales Growth Rate by Type (2013-2018)
Table Global Passive Transdermal Drug Delivery Revenue (Million USD) and Market Share by Type (2013-2018)
Table Global Passive Transdermal Drug Delivery Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Passive Transdermal Drug Delivery by Type (2013-2018)
Figure Global Passive Transdermal Drug Delivery Revenue Growth Rate by Type (2013-2018)
Table Global Passive Transdermal Drug Delivery Sales Volume (K Units) and Market Share by Region (2013-2018)
Table Global Passive Transdermal Drug Delivery Sales Share by Region (2013-2018)
Figure Sales Market Share of Passive Transdermal Drug Delivery by Region (2013-2018)
Figure Global Passive Transdermal Drug Delivery Sales Growth Rate by Region in 2017
Table Global Passive Transdermal Drug Delivery Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Passive Transdermal Drug Delivery Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Passive Transdermal Drug Delivery by Region (2013-2018)
Figure Global Passive Transdermal Drug Delivery Revenue Growth Rate by Region in 2017
Table Global Passive Transdermal Drug Delivery Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Passive Transdermal Drug Delivery Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Passive Transdermal Drug Delivery by Region (2013-2018)
Figure Global Passive Transdermal Drug Delivery Revenue Market Share by Region in 2017
Table Global Passive Transdermal Drug Delivery Sales Volume (K Units) and Market Share by Application (2013-2018)
Table Global Passive Transdermal Drug Delivery Sales Share (%) by Application (2013-2018)
Figure Sales Market Share of Passive Transdermal Drug Delivery by Application (2013-2018)
Figure Global Passive Transdermal Drug Delivery Sales Market Share by Application (2013-2018)
Figure United States Passive Transdermal Drug Delivery Sales (K Units) and Growth Rate (2013-2018)
Figure United States Passive Transdermal Drug Delivery Revenue (Million USD) and Growth Rate (2013-2018)
Figure United States Passive Transdermal Drug Delivery Sales Price (USD/Unit) Trend (2013-2018)
Table United States Passive Transdermal Drug Delivery Sales Volume (K Units) by Players (2013-2018)
Table United States Passive Transdermal Drug Delivery Sales Volume Market Share by Players (2013-2018)
Figure United States Passive Transdermal Drug Delivery Sales Volume Market Share by Players in 2017
Table United States Passive Transdermal Drug Delivery Sales Volume (K Units) by Type (2013-2018)
Table United States Passive Transdermal Drug Delivery Sales Volume Market Share by Type (2013-2018)
Figure United States Passive Transdermal Drug Delivery Sales Volume Market Share by Type in 2017
Table United States Passive Transdermal Drug Delivery Sales Volume (K Units) by Application (2013-2018)
Table United States Passive Transdermal Drug Delivery Sales Volume Market Share by Application (2013-2018)
Figure United States Passive Transdermal Drug Delivery Sales Volume Market Share by Application in 2017
Figure China Passive Transdermal Drug Delivery Sales (K Units) and Growth Rate (2013-2018)
Figure China Passive Transdermal Drug Delivery Revenue (Million USD) and Growth Rate (2013-2018)
Figure China Passive Transdermal Drug Delivery Sales Price (USD/Unit) Trend (2013-2018)
Table China Passive Transdermal Drug Delivery Sales Volume (K Units) by Players (2013-2018)
Table China Passive Transdermal Drug Delivery Sales Volume Market Share by Players (2013-2018)
Figure China Passive Transdermal Drug Delivery Sales Volume Market Share by Players in 2017
Table China Passive Transdermal Drug Delivery Sales Volume (K Units) by Type (2013-2018)
Table China Passive Transdermal Drug Delivery Sales Volume Market Share by Type (2013-2018)
Figure China Passive Transdermal Drug Delivery Sales Volume Market Share by Type in 2017
Table China Passive Transdermal Drug Delivery Sales Volume (K Units) by Application (2013-2018)
Table China Passive Transdermal Drug Delivery Sales Volume Market Share by Application (2013-2018)
Figure China Passive Transdermal Drug Delivery Sales Volume Market Share by Application in 2017
Figure Europe Passive Transdermal Drug Delivery Sales (K Units) and Growth Rate (2013-2018)
Figure Europe Passive Transdermal Drug Delivery Revenue (Million USD) and Growth Rate (2013-2018)
Figure Europe Passive Transdermal Drug Delivery Sales Price (USD/Unit) Trend (2013-2018)
Table Europe Passive Transdermal Drug Delivery Sales Volume (K Units) by Players (2013-2018)
Table Europe Passive Transdermal Drug Delivery Sales Volume Market Share by Players (2013-2018)
Figure Europe Passive Transdermal Drug Delivery Sales Volume Market Share by Players in 2017
Table Europe Passive Transdermal Drug Delivery Sales Volume (K Units) by Type (2013-2018)
Table Europe Passive Transdermal Drug Delivery Sales Volume Market Share by Type (2013-2018)
Figure Europe Passive Transdermal Drug Delivery Sales Volume Market Share by Type in 2017
Table Europe Passive Transdermal Drug Delivery Sales Volume (K Units) by Application (2013-2018)
Table Europe Passive Transdermal Drug Delivery Sales Volume Market Share by Application (2013-2018)
Figure Europe Passive Transdermal Drug Delivery Sales Volume Market Share by Application in 2017
Figure Japan Passive Transdermal Drug Delivery Sales (K Units) and Growth Rate (2013-2018)
Figure Japan Passive Transdermal Drug Delivery Revenue (Million USD) and Growth Rate (2013-2018)
Figure Japan Passive Transdermal Drug Delivery Sales Price (USD/Unit) Trend (2013-2018)
Table Japan Passive Transdermal Drug Delivery Sales Volume (K Units) by Players (2013-2018)
Table Japan Passive Transdermal Drug Delivery Sales Volume Market Share by Players (2013-2018)
Figure Japan Passive Transdermal Drug Delivery Sales Volume Market Share by Players in 2017
Table Japan Passive Transdermal Drug Delivery Sales Volume (K Units) by Type (2013-2018)
Table Japan Passive Transdermal Drug Delivery Sales Volume Market Share by Type (2013-2018)
Figure Japan Passive Transdermal Drug Delivery Sales Volume Market Share by Type in 2017
Table Japan Passive Transdermal Drug Delivery Sales Volume (K Units) by Application (2013-2018)
Table Japan Passive Transdermal Drug Delivery Sales Volume Market Share by Application (2013-2018)
Figure Japan Passive Transdermal Drug Delivery Sales Volume Market Share by Application in 2017
Figure Southeast Asia Passive Transdermal Drug Delivery Sales (K Units) and Growth Rate (2013-2018)
Figure Southeast Asia Passive Transdermal Drug Delivery Revenue (Million USD) and Growth Rate (2013-2018)
Figure Southeast Asia Passive Transdermal Drug Delivery Sales Price (USD/Unit) Trend (2013-2018)
Table Southeast Asia Passive Transdermal Drug Delivery Sales Volume (K Units) by Players (2013-2018)
Table Southeast Asia Passive Transdermal Drug Delivery Sales Volume Market Share by Players (2013-2018)
Figure Southeast Asia Passive Transdermal Drug Delivery Sales Volume Market Share by Players in 2017
Table Southeast Asia Passive Transdermal Drug Delivery Sales Volume (K Units) by Type (2013-2018)
Table Southeast Asia Passive Transdermal Drug Delivery Sales Volume Market Share by Type (2013-2018)
Figure Southeast Asia Passive Transdermal Drug Delivery Sales Volume Market Share by Type in 2017
Table Southeast Asia Passive Transdermal Drug Delivery Sales Volume (K Units) by Application (2013-2018)
Table Southeast Asia Passive Transdermal Drug Delivery Sales Volume Market Share by Application (2013-2018)
Figure Southeast Asia Passive Transdermal Drug Delivery Sales Volume Market Share by Application in 2017
Figure India Passive Transdermal Drug Delivery Sales (K Units) and Growth Rate (2013-2018)
Figure India Passive Transdermal Drug Delivery Revenue (Million USD) and Growth Rate (2013-2018)
Figure India Passive Transdermal Drug Delivery Sales Price (USD/Unit) Trend (2013-2018)
Table India Passive Transdermal Drug Delivery Sales Volume (K Units) by Players (2013-2018)
Table India Passive Transdermal Drug Delivery Sales Volume Market Share by Players (2013-2018)
Figure India Passive Transdermal Drug Delivery Sales Volume Market Share by Players in 2017
Table India Passive Transdermal Drug Delivery Sales Volume (K Units) by Type (2013-2018)
Table India Passive Transdermal Drug Delivery Sales Volume Market Share by Type (2013-2018)
Figure India Passive Transdermal Drug Delivery Sales Volume Market Share by Type in 2017
Table India Passive Transdermal Drug Delivery Sales Volume (K Units) by Application (2013-2018)
Table India Passive Transdermal Drug Delivery Sales Volume Market Share by Application (2013-2018)
Figure India Passive Transdermal Drug Delivery Sales Volume Market Share by Application in 2017
Table 3M Basic Information List
Table 3M Passive Transdermal Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure 3M Passive Transdermal Drug Delivery Sales Growth Rate (2013-2018)
Figure 3M Passive Transdermal Drug Delivery Sales Global Market Share (2013-2018)
Figure 3M Passive Transdermal Drug Delivery Revenue Global Market Share (2013-2018)
Table Actavis, Inc. Basic Information List
Table Actavis, Inc. Passive Transdermal Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Actavis, Inc. Passive Transdermal Drug Delivery Sales Growth Rate (2013-2018)
Figure Actavis, Inc. Passive Transdermal Drug Delivery Sales Global Market Share (2013-2018)
Figure Actavis, Inc. Passive Transdermal Drug Delivery Revenue Global Market Share (2013-2018)
Table Bayer AG Basic Information List
Table Bayer AG Passive Transdermal Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Bayer AG Passive Transdermal Drug Delivery Sales Growth Rate (2013-2018)
Figure Bayer AG Passive Transdermal Drug Delivery Sales Global Market Share (2013-2018
Figure Bayer AG Passive Transdermal Drug Delivery Revenue Global Market Share (2013-2018)
Table Boehringer Ingelheim GmbH Basic Information List
Table Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Sales Growth Rate (2013-2018)
Figure Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Sales Global Market Share (2013-2018)
Figure Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Revenue Global Market Share (2013-2018)
Table Corium International, Inc. Basic Information List
Table Corium International, Inc. Passive Transdermal Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Corium International, Inc. Passive Transdermal Drug Delivery Sales Growth Rate (2013-2018)
Figure Corium International, Inc. Passive Transdermal Drug Delivery Sales Global Market Share (2013-2018)
Figure Corium International, Inc. Passive Transdermal Drug Delivery Revenue Global Market Share (2013-2018)
Table Echo Therapeutics, Inc. Basic Information List
Table Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Sales Growth Rate (2013-2018)
Figure Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Sales Global Market Share (2013-2018
Figure Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Revenue Global Market Share (2013-2018)
Table GlaxoSmithKline plc Basic Information List
Table GlaxoSmithKline plc Passive Transdermal Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure GlaxoSmithKline plc Passive Transdermal Drug Delivery Sales Growth Rate (2013-2018)
Figure GlaxoSmithKline plc Passive Transdermal Drug Delivery Sales Global Market Share (2013-2018)
Figure GlaxoSmithKline plc Passive Transdermal Drug Delivery Revenue Global Market Share (2013-2018)
Table Johnson & Johnson (Janssen Pharmaceuticals Inc.) Basic Information List
Table Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Sales Growth Rate (2013-2018)
Figure Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Sales Global Market Share (2013-2018
Figure Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Revenue Global Market Share (2013-2018)
Table Mylan N.V. Basic Information List
Table Mylan N.V. Passive Transdermal Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Mylan N.V. Passive Transdermal Drug Delivery Sales Growth Rate (2013-2018)
Figure Mylan N.V. Passive Transdermal Drug Delivery Sales Global Market Share (2013-2018)
Figure Mylan N.V. Passive Transdermal Drug Delivery Revenue Global Market Share (2013-2018)
Table Novartis AG Basic Information List
Table Novartis AG Passive Transdermal Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Novartis AG Passive Transdermal Drug Delivery Sales Growth Rate (2013-2018)
Figure Novartis AG Passive Transdermal Drug Delivery Sales Global Market Share (2013-2018)
Figure Novartis AG Passive Transdermal Drug Delivery Revenue Global Market Share (2013-2018)
Table Noven Pharmaceuticals, Inc. Basic Information List
Table Transdermal Corp. Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Passive Transdermal Drug Delivery
Figure Manufacturing Process Analysis of Passive Transdermal Drug Delivery
Figure Passive Transdermal Drug Delivery Industrial Chain Analysis
Table Raw Materials Sources of Passive Transdermal Drug Delivery Major Players in 2017
Table Major Buyers of Passive Transdermal Drug Delivery
Table Distributors/Traders List
Figure Global Passive Transdermal Drug Delivery Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Global Passive Transdermal Drug Delivery Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Passive Transdermal Drug Delivery Price (USD/Unit) and Trend Forecast (2018-2025)
Table Global Passive Transdermal Drug Delivery Sales Volume (K Units) Forecast by Regions (2018-2025)
Figure Global Passive Transdermal Drug Delivery Sales Volume Market Share Forecast by Regions (2018-2025)
Figure Global Passive Transdermal Drug Delivery Sales Volume Market Share Forecast by Regions in 2025
Table Global Passive Transdermal Drug Delivery Revenue (Million USD) Forecast by Regions (2018-2025)
Figure Global Passive Transdermal Drug Delivery Revenue Market Share Forecast by Regions (2018-2025)
Figure Global Passive Transdermal Drug Delivery Revenue Market Share Forecast by Regions in 2025
Figure United States Passive Transdermal Drug Delivery Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States Passive Transdermal Drug Delivery Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure China Passive Transdermal Drug Delivery Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure China Passive Transdermal Drug Delivery Revenue and Growth Rate Forecast (2018-2025)
Figure Europe Passive Transdermal Drug Delivery Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Europe Passive Transdermal Drug Delivery Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Japan Passive Transdermal Drug Delivery Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Japan Passive Transdermal Drug Delivery Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Passive Transdermal Drug Delivery Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Passive Transdermal Drug Delivery Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure India Passive Transdermal Drug Delivery Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure India Passive Transdermal Drug Delivery Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Global Passive Transdermal Drug Delivery Sales (K Units) Forecast by Type (2018-2025)
Figure Global Passive Transdermal Drug Delivery Sales Volume Market Share Forecast by Type (2018-2025)
Table Global Passive Transdermal Drug Delivery Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Passive Transdermal Drug Delivery Revenue Market Share Forecast by Type (2018-2025)
Table Global Passive Transdermal Drug Delivery Price (USD/Unit) Forecast by Type (2018-2025)
Table Global Passive Transdermal Drug Delivery Sales (K Units) Forecast by Application (2018-2025)
Figure Global Passive Transdermal Drug Delivery Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


More Publications